Free Trial

Cara Therapeutics (TVRD) Stock Trends and Sentiment

$33.39 +4.30 (+14.78%)
As of 04:00 PM Eastern

MarketBeat Searches Over Time



Recieve Cara Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for TVRD and its competitors with MarketBeat's FREE daily newsletter.

TVRD Social Media Mentions

Related Companies and Tools


This page (NASDAQ:TVRD) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners